Diabetic Macular Edema

• FDA label_change · 2023-12-14
  FDA Approved: EYLEA HD — Supplemental Application (Regeneron Pharmaceuticals, Inc)

  FDA approved a supplemental application for EYLEA HD (aflibercept) from Regeneron, indicating a labeling change for the high-dose formulatio…

• FDA label_change · 2010-08-31
  FDA Approved: OZURDEX — Supplemental Application (Allergan, Inc.)

  FDA approved a supplemental application for OZURDEX (dexamethasone) from Allergan, Inc., likely resulting in changes to the product labeling…